Stroke Trial, Recruiting NCT04517383 Sponsor: RenJi Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04517383
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 85 years old
  • People who have been diagnosed with an acute ischaemic stroke (a stroke caused by a blocked artery) affecting the front part of the brain, involving a major artery such as the internal carotid artery or middle cerebral artery
  • People whose stroke symptoms were rated as moderately severe or worse (a score of 10 or higher on a standard medical stroke assessment scale) before the procedure
  • People who were largely independent in daily life (low disability score) before the stroke occurred
  • People who underwent a procedure to remove the blood clot from the blocked artery while under general anaesthetic, and where the procedure successfully restored blood flow, as confirmed by a specialised imaging test at the end of the operation
  • People who have given informed consent themselves, or whose legal representative has done so on their behalf

Who may not be able to join:

  • People who have had a bleed inside the brain within the past 6 weeks
  • People who have had a stent placed in the artery responsible for the stroke
  • People who had a very low level of consciousness (a Glasgow Coma Scale score of 8 or below) before the procedure
  • People with a known allergy to heparin, aspirin, clopidogrel, rapamycin, lactic acid polymer, stainless steel, or to contrast dye used in imaging
  • People for whom a specific sedative medication called dexmedetomidine is not medically suitable
  • People with very low haemoglobin (a measure of red blood cells), very low platelet levels (cells that help blood clot), abnormal blood clotting results, or other bleeding problems that cannot be corrected
  • People with serious liver or kidney problems, based on blood test results that are significantly outside the normal range
  • People who are pregnant or breastfeeding
  • People with a known history of mental illness
  • People who are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-21-68383702

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
24 November 2021
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the score on the modified Rankin Scale assessed at 90±7 days after randomization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov